TELA Bio TELA
NASDAQ TELA
$0.85 -0.06 (-6.40%)
As of: Sep 10, 2026 · 1:18 PM EDT

TELA Bio (TELA) Gross Margin Growth (3y) (2021 - 2026)

Analysis

TELA Bio (TELA) Gross Margin Growth (3y) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Abbott Laboratories 180.74 Bn 175.14 Bn 7.27 Bn 264.00
2 Intuitive Surgical 127.56 Bn 122.34 Bn 1.96 Bn 104.00
3 Medtronic 116.90 Bn 108.08 Bn 6.34 Bn -89.00
4 Stryker 103.85 Bn 100.37 Bn 4.50 Bn 459.00
5 Boston Scientific 63.70 Bn 63.16 Bn 3.85 Bn 8.00
6 Edwards Lifesciences 49.88 Bn 45.63 Bn 1.35 Bn -316.00
7 Alcon 33.04 Bn 31.59 Bn 1.68 Bn 393.00
8 Dexcom 32.18 Bn 30.23 Bn 830.00 Mn 73.00
9 Steris 20.65 Bn 20.17 Bn 684.20 Mn 113.00
10 TELA Bio 48.87 Mn 18.44 Mn 13.94 Mn 190.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 190.00
Mar 31, 2026 -63.00
Dec 31, 2025 -444.00
Sep 30, 2025 193.00
Jun 30, 2025 689.00
Mar 31, 2025 683.00
Dec 31, 2024 -400.00
Sep 30, 2024 770.00
Jun 30, 2024 151.00
Mar 31, 2024 932.00
Dec 31, 2023 376.00
Sep 30, 2023 715.00
Jun 30, 2023 1,093.00
Mar 31, 2023 728.00
Dec 31, 2022 943.00
Sep 30, 2022 5.00
Jun 30, 2022 521.00
Mar 31, 2022 635.00
Dec 31, 2021 2,522.00
Sep 30, 2021 -167.00